| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 16,502,000 | 12,664,000 | 15,293,000 | 16,962,000 | | Cost of Revenue | 13,745,000 | 11,437,000 | 12,487,000 | 13,885,000 | | | Gross Profit | 2,757,000 | 1,227,000 | 2,806,000 | 3,077,000 | | | Operating Expenses | | Research Development | 970,000 | 957,000 | 937,000 | 1,005,000 | | Selling General and Administrative | 759,000 | 734,000 | 740,000 | 835,000 | | Non Recurring | 3,000 | 193,000 | (195,000) | (2,000) | | Others |
-
| (241,000) |
-
|
-
| | | | Total Operating Expenses |
-
| 1,643,000 |
-
|
-
| | | | Operating Income or Loss | 1,025,000 | (416,000) | 1,324,000 | 1,239,000 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (36,000) | (10,000) | (68,000) | 167,000 | | Earnings Before Interest And Taxes | 989,000 | (426,000) | 1,256,000 | 1,406,000 | | Interest Expense | 57,000 | (116,000) | 103,000 | 107,000 | | Income Before Tax | 932,000 | (310,000) | 1,153,000 | 1,299,000 | | Income Tax Expense | 317,000 | (224,000) | 470,000 | 448,000 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 615,000 | (86,000) | 683,000 | 851,000 | | | Non-recurring Events | | Discontinued Operations | (5,000) |
-
| 12,000 | 1,000 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 610,000 | (86,000) | 695,000 | 852,000 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $610,000 | ($86,000) | $695,000 | $852,000 |
|
3.07% Nasdaq 
Income Statement
